Florida prosecutors and Tiger Woods' defense team are locked in a legal battle over whether the state can subpoena the golfer's prescription drug records, a dispute that pits the government's interest in proving impaired driving against a defendant's constitutional privacy rights.
The clash stems from Woods' arrest earlier this year after his SUV clipped a trailer and rolled onto its side on Jupiter Island. Deputies at the scene reported signs of impairment, found two pain pills in his pocket, and recorded a 0.00 on a breath test. Woods refused a urine test. He has pleaded not guilty and demanded a jury trial.
Martin County prosecutors told the court they plan to subpoena all of Woods' prescription medication records on file at Lewis Pharmacy in Palm Beach, covering January 1 through March 27, the date of the crash and arrest. The Daily Mail first detailed the scope of the records fight, which has become the central pretrial flashpoint in the case.
The subpoena would not simply confirm whether Woods held active prescriptions. The Washington Times reported that prosecutors want the times each prescription was filled, the number of pills dispensed, dosage amounts, and any instructions or warnings that accompanied the medication, including warnings about driving while taking them.
That last detail matters. In a DUI prosecution where alcohol has been ruled out, the state's path to conviction runs through proof that a specific substance caused impairment. Pharmacy dispensing records, complete with dosage information and printed warnings, could give prosecutors the documentary backbone they need to connect a particular drug to the behavior deputies observed at the scene.
Woods' attorney, Douglas Duncan, filed a motion to block the subpoena. His argument rests on a straightforward constitutional claim: prescription medication records fall within a zone of privacy that the government cannot breach without clearing a higher bar. AP News reported that Duncan said Woods "has a constitutional right to privacy" regarding his prescription medications and requested a hearing on whether the records are necessary to the prosecution's case.
In his court filing, Duncan acknowledged the right is not absolute. He wrote that it could yield if the state demonstrates the records are relevant to its criminal investigation and that the intrusion into Woods' privacy is warranted. But he signaled the defense does not believe prosecutors have met that threshold.
"This right is admittedly not absolute should the State show the relevance of the records to its criminal investigation and thus warrant intrusion into Mr. Woods' privacy."
The motion effectively forces a judge to weigh in before any pharmacy turns over documents. That hearing has not yet been scheduled, and no ruling has been issued.
When high-profile figures face public scrutiny over medical matters, the legal system must balance transparency against individual rights, a tension that has surfaced in contexts ranging from Justice Alito's hospital visit and the questions it raised about his Supreme Court tenure to celebrity drug cases that dominate national headlines.
The facts surrounding the arrest itself set the stage for the records fight. Deputies who responded to the single-vehicle crash on Jupiter Island reported that Woods appeared lethargic during field sobriety testing. Fox News reported that authorities said Woods blew "triple-zeroes" on the breath test, effectively eliminating alcohol as the cause of any impairment. Deputies believed he was under the influence of an "unknown substance."
Two pain pills were found in Woods' pocket. He refused a urine test, which in Florida can carry its own legal consequences but also deprives investigators of direct toxicological evidence. That refusal helps explain why prosecutors turned to pharmacy records as an alternative route to establishing what substances Woods may have had in his system.
CLN previously covered Woods' arrest on the DUI charge after the rollover crash, which drew immediate national attention given his status as one of the most recognized athletes in the world.
Florida law treats prescription records with a degree of sensitivity that goes beyond ordinary business records. Medical and pharmacy records implicate privacy interests under both the Fourth Amendment and the Florida Constitution, which contains an explicit right-to-privacy provision that is broader than its federal counterpart.
For prosecutors, the challenge is showing that the records are not a fishing expedition but a targeted effort to identify a specific substance linked to observed impairment. The breath test cleared alcohol. The refused urine test left no lab results. The pills in Woods' pocket suggest a prescription medication, but without pharmacy records, prosecutors may struggle to prove what drug, at what dose, and with what known side effects Woods may have consumed before driving.
For the defense, the risk is that a judge grants the subpoena and the records reveal a medication with explicit warnings against operating heavy machinery, a fact that could be devastating at trial. Duncan's strategy appears aimed at keeping that door shut or, at minimum, narrowing what the state can obtain.
Prescription drug issues have become a recurring flashpoint in both criminal law and civil litigation. The question of who controls access to medication records, and under what circumstances the government can compel disclosure, touches on debates that extend well beyond any single DUI case. Similar tensions over pharmacy access and drug-related legal battles have played out in federal antitrust litigation over prescription drug middlemen, where the structure of the pharmacy system itself came under judicial scrutiny.
While the legal fight over records plays out in Martin County, Woods has taken a personal step that his defense team will likely reference as the case progresses. He released a public statement acknowledging the gravity of his situation.
"I know and understand the seriousness of the situation I find myself in today. I am stepping away for a period of time to seek treatment and focus on my health."
Breitbart reported that Woods has sought inpatient treatment abroad. That decision could cut both ways in court. Prosecutors may argue it confirms Woods recognized a substance-abuse problem. The defense may frame it as responsible self-care that demonstrates Woods is addressing the issue without the need for invasive government access to his private medical history.
Celebrity cases involving drugs and medical substances often carry consequences that ripple far beyond the individual defendant. The prosecution of the woman known as the "Ketamine Queen," who received 15 years in federal prison for Matthew Perry's fatal overdose, illustrated how aggressively the justice system can pursue drug-related cases when a famous name is involved.
The immediate question is whether a Martin County judge will grant a hearing on Duncan's motion and, if so, whether the court will quash the subpoena, allow it in full, or impose limits on what prosecutors can obtain. Investigators have not publicly confirmed whether they possess any other evidence linking a specific substance to Woods' behavior that night. No toxicology results from the arrest have been released.
Woods' not-guilty plea and demand for a jury trial signal that the defense intends to fight the case on every front. The prescription records battle is the first major skirmish, but it will not be the last. If the records come in, prosecutors gain a powerful tool. If they stay sealed, the state will need to build its impairment case on deputy observations, field sobriety results, and the pills found in Woods' pocket, without the pharmacological context that could tie it all together.
When the government wants your medical records and your lawyer says no, the courtroom is exactly where that fight belongs. How this judge rules will say something about where the line sits between law enforcement's reach and a citizen's right to keep his prescriptions private.
